Literature DB >> 9871640

S-aryl cysteine S,S-dioxides as inhibitors of mammalian kynureninase.

M J Drysdale1, J F Reinhard.   

Abstract

A series of 2-amino-S-aryl cysteine S,S-dioxides have been synthesised and shown to inhibit kynureninase an important enzyme in the biosynthesis of the known excitotoxic moiety quinolinic acid. The most potent of these, 2-amino-5-methyl-S-phenyl cysteine S,S-dioxide 6d, inhibits interferon-gamma induced synthesis of quinolinic acid in human macrophages.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9871640     DOI: 10.1016/s0960-894x(97)10209-8

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Generating Stereodiversity: Diastereoselective Fluorination and Highly Diastereoselective Epimerization of α-Amino Acid Building Blocks.

Authors:  Wei Wei; Rama Kanwar Khangarot; Lothar Stahl; Cristina Veresmortean; Padmanava Pradhan; Lijia Yang; Barbara Zajc
Journal:  Org Lett       Date:  2018-06-01       Impact factor: 6.005

Review 2.  Kynurenines in the CNS: recent advances and new questions.

Authors:  László Vécsei; Levente Szalárdy; Ferenc Fülöp; József Toldi
Journal:  Nat Rev Drug Discov       Date:  2012-12-14       Impact factor: 84.694

Review 3.  Structure, mechanism, and substrate specificity of kynureninase.

Authors:  Robert S Phillips
Journal:  Biochim Biophys Acta       Date:  2010-12-15

Review 4.  Major Developments in the Design of Inhibitors along the Kynurenine Pathway.

Authors:  Kelly R Jacobs; Gloria Castellano-Gonzalez; Gilles J Guillemin; David B Lovejoy
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

Review 5.  KYNU, a novel potential target that underpins CD44-promoted breast tumour cell invasion.

Authors:  Maryam Al-Mansoob; Ishita Gupta; Radoslaw Stefan Rusyniak; Allal Ouhtit
Journal:  J Cell Mol Med       Date:  2021-01-24       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.